NCT04107675: A trial that was reported late by Zambon SpA
This trial has reported, although it was 3 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04107675 |
|---|---|
| Title | A Phase IIa Multi-Center, Randomized, Single-Blind Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 11, 2020 |
| Completion date | June 16, 2022 |
| Required reporting date | June 16, 2023, midnight |
| Actual reporting date | June 19, 2023 |
| Date last checked at ClinicalTrials.gov | June 26, 2026 |
| Days late | 3 |